Send to a Friend Share

Ladenburg Thalmann Downgrades Optimer Pharmaceuticals (OPTR) to Neutral

November 4, 2009 12:31 PM EST
OPTR Hot Sheet
Rating Summary:
    6 Buy, 3 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 16 | Down: 7 | New: 23
Ladenburg Thalmann downgrades Optimer Pharmaceuticals (Nasdaq: OPTR) from Buy to Neutral. Price target lowered from $17 to $13.50.

To see more analyst ratings on OPTR Click Here.


You May Also Be Interested In


Related Categories

Downgrades

Related Entities

Ladenburg Thalmann Financial Services

Add Your Comment





Follow StreetInsider.com On Twitter